...
首页> 外文期刊>Thoracic cancer. >Transcriptional regulation of autophagy‐lysosomal pathway in cancer
【24h】

Transcriptional regulation of autophagy‐lysosomal pathway in cancer

机译:癌症中自噬 - 溶酶体途径的转录调控

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The transcriptional regulation of autophagy-lysosomal pathway adapts to cellular stress and enables advanced cancer cells survive. This pathway plays an oncopromoting or oncosuppressing role, depending on context-dependent stresses and treatment resistance. It remains controversial whether this pathway represents a target for drugs, although autophagy-lysosomal inducers and inhibitors have been tested in clinical trials for cancer treatment. Therefore, identifying the transcriptional regulators of autophagy-lysosomal pathway may lead to the development of effective cancer treatment and the improvement of the existing targeted cancer therapies. In this review, we summarize findings from several published studies on transcriptional regulation of autophagy-lysosomal pathway in cancer biology, and evaluate its functional role as a therapeutic target.? 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:自噬 - 溶酶体途径的转录调节适应细胞应激,使先进的癌细胞生存能力。该途径根据上下文依赖性的应力和治疗抵抗,发挥鞘内或肿瘤抑制作用。仍然存在争议,但这种途径是否代表着药物的靶标,尽管已在癌症治疗的临床试验中进行了自噬溶酶体诱导剂和抑制剂。因此,鉴定自噬溶酶体途径的转录调节剂可能导致有效癌症治疗的发展和现有靶向癌症疗法的改善。在这篇综述中,我们总结了几次公布的癌症生物学中自噬 - 溶酶体途径转录调控的研究结果,并评估其作为治疗目标的功能作用。 2020作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号